Estrogen Blocking - Aromatase Inhibition - Prostate
A powerful blend of herbal extracts that assist the body in maintaining healthy levels of estrogen. Together, these ingredients work synergestically to control harmful estrogen by either "blocking" the action of estrogen in the body or by the aromatase inhibition (blocking the making) of estradiol and estrone: the two most dangerous and carcinogenic forms of estrogen.*
Chrysin Extract (Seeds): Chrysin has been reported to be an aromatase inhibitor as well as as a testosterone booster.* It has also been thought to have some anti-inflammatory effects in the otherwise normal healthy body.*
New studies may indicate that Chrysin may be used to protect and normalize age-related cognitive decline in an otherwise healthy individual.*
Nettle Root Extract (Root): Nettle root extracts have been used in bodybuilding to help the body increase it's natural free testosterone with some recent studies indicating that it may also have some anti-inflammatory benefits during weight training.*
Pygeum Africanum Bark Extract (Bark): Pygeum africanum bark has been used medicinally for thousands of years to support healthy bladder and urination processes, and especially normal prostate health.*
Serrapeptase: Serrapeptase helps absorption and enhances the benefits of the herbs in this blend.
Below, please find research articles and study abstracts that further detail the benefits of some of the active ingredients in Andeanessence.*
These studies have been sourced and linked to from online medical research sites. If you'd like to learn more, please click HERE and search by ingredient name.
Disclaimer: This section is for educational purposes only. There is no guarantee the product will have these same benefits for everyone. Individual results may vary.*
Benign prostatic hyperplasia (BPH), nonmalignant enlargement of the prostate, can lead to obstructive and irritative lower urinary tract symptoms (LUTS). The pharmacologic use of plants and herbs (phytotherapy) for the treatment of LUTS associated with BPH has been growing steadily. The extract of the African prune tree, Pygeum africanum, is one of the several phytotherapeutic agents available for the treatment of BPH.
To investigate the evidence whether extracts of Pygeum africanum (1) are more effective than placebo in the treatment of Benign Prostatic Hyperplasia (BPH), (2) are as effective as standard pharmacologic BPH treatments, and (3) have less side effects compared to standard BPH drugs.
Trials were searched in computerized general and specialized databases (MEDLINE (1966 to 2000), EMBASE, Cochrane Library, Phytodok), by checking bibliographies, and by contacting relevant manufacturers and researchers.
Trials were eligible if they (1) were randomized (2) included men with BPH (3) compared preparations of Pygeum africanum (alone or in combination) with placebo or other BPH medications (4) included clinical outcomes such as urologic symptom scales, symptoms, or urodynamic measurements. Eligibility was assessed by at least two independent observers.
Information on patients, interventions, and outcomes were extracted by at least two independent reviewers using a standard form. The main outcome measure for comparing the effectiveness of Pygeum africanum with placebo and standard BPH medications was the change in urologic symptoms scale scores. Secondary outcomes included change in urologic symptoms including nocturia and urodynamic measures (peak and mean urine flow, prostate size). The main outcome measure for adverse effects was the number of men reporting adverse effects.
A total of 18 randomized controlled trials involving 1562 men met inclusion criteria and were analyzed. Only one of the studies reported a method of treatment allocation concealment, though 17 were double blinded. There were no studies comparing Pygeum africanum to standard pharmacologic interventions such as alpha‐adrenergic blockers or 5‐alpha reductase inhibitors. The mean study duration was 64 days (range, 30 to 122 days). Many studies did not report results in a method that permitted meta‐analysis. Compared to men receiving placebo, Pygeum africanum provided a moderately large improvement in the combined outcome of urologic symptoms and flow measures as assessed by an effect size defined by the difference of the mean change for each outcome divided by the pooled standard deviation for each outcome (‐0.8 SD [95% confidence interval (CI), ‐1.4 to ‐0.3 (n = 6 studies)]). Men using Pygeum africanum were more than twice as likely to report an improvement in overall symptoms (RR=2.1, 95% CI = 1.4 to 3.1). Nocturia was reduced by 19%, residual urine volume by 24% and peak urine flow was increased by 23%. Adverse effects due to Pygeum Africanum were mild and comparable to placebo. The overall dropout rate was 12% and was similar between Pygeum Africanum (13%), placebo (11%) and other controls (8%).
A standardized preparation of Pygeum africanum may be a useful treatment option for men with lower urinary symptoms consistent with benign prostatic hyperplasia. However, the reviewed studies were small in size, were of short duration, used varied doses and preparations and rarely reported outcomes using standardized validated measures of efficacy. Additional placebo‐controlled trials are needed as well as studies that compare Pygeum africanum to active controls that have been convincingly demonstrated to have beneficial effects on lower urinary tract symptoms related to BPH. These trials should be of sufficient size and duration to detect important differences in clinically relevant endpoints and use standardized urologic symptom scale scores.
Prostate cancer remains one of the major causes of death worldwide. In view of the limited treatment options for patients with prostate cancer, preventive and treatment approaches based on natural compounds can play an integral role in tackling this disease. Recent evidence supports the beneficial effects of plant-derived phytochemicals as chemopreventive and chemotherapeutic agents for various cancers, including prostate cancer. Prunus africana has been used for generations in African traditional medicine to treat prostate cancer. This review examined the potential roles of the phytochemicals from P. africana, an endangered, sub-Saharan Africa plant in the chemoprevention and chemotherapy of prostate cancer. In vitro and in vivo studies have provided strong pharmacological evidence for antiprostate cancer activities of P. africana-derived phytochemicals. Through synergistic interactions between different effective phytochemicals, P. africana extracts have been shown to exhibit very strong antiandrogenic and antiangiogenic activities and have the ability to kill tumor cells via apoptotic pathways, prevent the proliferation of prostate cancer cells, and alter the signaling pathways required for the maintenance of prostate cancer cells. However, further preclinical and clinical studies ought to be done to advance and eventually use these promising phytochemicals for the prevention and chemotherapy of human prostate cancer.
Stinging nettle (Urtica dioica L.) is a wild herbaceous perennial blooming plant that is commonly known as stinging nettle. It’s a common, multi-purpose crop that’s sometimes overlooked. Europe, Asia, North Africa, and North America are all home to stinging nettle. It is a plant that’s edible and has nutritional and medicinal properties. Young leaves can be used to make curries, herb soups, and sour soups. The root of the stinging nettle is used to treat mictional difficulties associated with benign prostatic hyperplasia, while the leaves are used to treat arthritis, rheumatism, and allergic rhinitis. Its leaves are abundant in fiber, minerals, vitamins, and antioxidant compounds like polyphenols and carotenoids, as well as antioxidant compounds like polyphenols and carotenoids. Stinging nettle has antiproliferative, anti-inflammatory, antioxidant, analgesic, anti-infectious, hypotensive, and antiulcer characteristics, as well as the ability to prevent cardiovascular disease, in all parts of the plant (leaves, stems, roots, and seeds). Stinging nettle improves fish reproductive performance, making it a cost-effective aquaculture plant. Fertilizer and insecticides can be made from the plants. This review examines the nutritional and pharmacological aspects of stinging nettle, as well as its possible health advantages. Scientists, farmers, and academicians interested in stinging nettle collecting, cultivation, research, and development would find this review useful.
Note: We invite you to read the entire study as it talks more indepth about the specific health benefits that it outlines in the below figure 1
Polar extracts of the stinging nettle (Urtica dioica L.) roots contain the ligans (+)-neoolivil, (-)-secoisolariciresinol, dehydrodiconiferyl alcohol, isolariciresinol, pinoresinol, and 3,4-divanillyltetrahydrofuran. These compounds were either isolated from Urtica roots, or obtained semisynthetically. Their affinity to human sex hormone binding globulin (SHBG) was tested in an in vitro assay. In addition, the main intestinal transformation products of plant lignans in humans, enterodiol and enterolactone, together with enterofuran were checked for their activity. All lignans except (-)-pinoresinol developed a binding affinity to SHBG in the in vitro assay. The affinity of (-)-3,4-divanillyltetrahydrofuran was outstandingly high. These findings are discussed with respect to potential beneficial effects of plant lignans on benign prostatic hyperplasia (BPH).
This study was undertaken to evaluate a possible effect of the extracts PY102 of Pygeum africanum (Hook), and UR 102 of Urtica dioica L. as well as their combination PHL-00801 (Prostatonin®) on the enzymes 5 α-reductase (5 α-RE) and aromatase (AR): Inhibition of 5 α-RE: Pygeum africanum extract PY 102, and Urtica dioica extract UR 102, inhibited the 5 α-RE activity in a concentration dependent manner. Whereas UR102 extract was only able to influence the enzyme activity at high concentrations (≥ 12mg/ml) and its ED(50) being calculated as 14.7mg/ml, the PY102 extract showed a much higher activity starting with low concentrations (0.1 mg/ml) its ED(50) being calculated as 0.78 mg/ml. When compared with the effects of UR 102, the combination of both extracts, PHL-00801 (Prostatonin®), led to a similar inhibition of the enzyme (ED(50) 14.15 mg/ml). Inhibition of AR: The PY 102 extract showed a concentration dependent and strong activity (ED(50) = 0.98 mg/ml). The activity of the UR 102 extract was also concentration dependent (ED(50) = 3.58 mg/ml). The combination of both extracts, PHL-00801 (Prostatonin®) showed a synergistic action and significantly (p = 0.05) increased the AR-inhibitory activity in concentrations as low as 0.1 mg/ml (ED(50) 0.24 mg/ml). These observations are an explanation for the beneficial effects of PHL-00801 (Prostatonin®) observed in the clinical studies on BPH.
Copyright © 1996 Gustav Fischer Verlag · Stuttgart · Jena · New York. Published by Elsevier GmbH.. All rights reserved.
Office Hours:
When We Ship:
How We Ship
Within the USA:
International Shipping:
You may return most new, unopened items within 30 days of delivery for a refund of the purchase price less a 15% restocking fee and any shipping charges. The return item(s) must be in their original condition (unopened and unused) and accompanied by a copy of the original order form/packing list.
For health and safety reasons, we are unable to accept returns of personal care items such as lotions or creams.
No returns or refunds on unsealed (ie: opened) items, creams and books. No exceptions!
If you need to return an item, please contact us with your order number and details about the product you would like to return. We will respond quickly with a Return Authorization (RA) number and instructions for how to return the items. Returned items without a RA number will not be processed.
Items can be returned via any carrier you choose. We recommend you send the items insured, signature required.
Please mail to:
WAM Essentials, Inc; 320 Grant Ave; Strawn; TX 76475
Please see below for answers to some commonly asked questions.
In the event that you receive your package and it is missing an item or includes an incorrect item, we must be contacted within three (3) business days of receipt of the package for resolution/ answers. No refund/return can be issued if more than three (3) business days pass without an attempt to contact us.
If you have a questions about packing (ie: safety seals, mfg vs expiration dates, lid liners, etc), we must be contacted within three (3) business days of receipt of the package for resolution/ answers. No refund/return can be issued if more than three (3) business days pass without an attempt to contact us.
Please see below for the most commonly asked questions about Sinest®. We will continually add more FAQs to this as more questions come in to us.
Yes, the Sinest® is designed to be taken at night before bed, when the body's systems are quiet and it can work its best.
Yes, you can confidently take the Sinest® with other supplements.
Karuna
From the Karunahealth.net website:"Progesterone, a hormone derived primarily from the corpus luteum and secondarily from the adrenal gland and the male testes is a precursor hormone which can be...
